14th DIA Japan Annual Meeting 2017

Tokyo Big Sight

A Tale of Two Horizons and a Quest for New Thinking-Patient Access in the Age of Innovation

By Thomas Allvin

Go to any medical congress, read any medical journal, and you will face an avalanche of scientific discoveries larger than the...

Canada’s Emerging Approach to Opioid Management

By Judith Glennie

Concerns regarding the inappropriate use, abuse, and diversion of prescription narcotics have been discussed in the health field...

DIA Brexit Summit | Ensuring Continuity for Patients and Business

Millennium Hotel London Mayfair

Accelerated Pathways Work—Now What? Survey of US Payers

By Barry Farrimond, MSc; Jonathan J. Fleming, MPA; Mark Mathieu, MA

The US FDA has developed numerous accelerated pathways (APs) to facilitate faster development and approval of innovative drugs...

DIA EUROPE 2018

Congress Center Basel

Value Frameworks to Assess Health Technologies

By Rebecca Trowman, Dr. Wija Oortwijn, Dr. Laura Sampietro-Colom

Health Technology Assessment (HTA) is defined as a “the systematic evaluation of the properties of a health technology...

10th DIA China Annual Meeting

Beijing International Convention Center

Emerging Voice of Payers – Can They Support Innovation?

By Inka Heikkinen

Innovative medicines and future treatments are often accompanied by the uncertainty of affordability. As treatments become...

Paediatric Regulation Ten Years On

By Christina Bucci-Rechtweg, MD

The paediatric population is primarily healthy, rendering paediatric drug development research challenging due to the limited...

DIA 2018 Global Annual Meeting

Boston Convention and Exhibition Center